$MCS

Stonex raises Marcus Corp. stock estimates on strong box office

Stonex analyst Mike Hickey raised Marcus Corp. (MCS) estimates for Q3 FY2026, citing strong box office performance. Revenue estimate increased to $233M from $208M, and adjusted EBITDA to $42M from $37M. MCS stock is up 77% YTD, trading at $27.13. The company reported strong Q2 FY2026 results, exceeding earnings and revenue expectations.

Original reporting
Published Oct 9, 2026, 2:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 2:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$MCS
Bullish
medium confidence
Mentioned
$MCS
Relevance
5/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$MCSBullishMed
01

Why it matters

The upgraded estimates provide fresh upside potential for the stock.

02

Market read

Analyst raises guidance after strong earnings, creating a modest trade idea.

03

What to watch

Potential headwinds from the July 4 holiday and competition from streaming services.

Relevance 5/10Novelty 4/10Timing: today

Background

The article recaps Marcus Corp.'s recent earnings beat and adds a new analyst forecast upgrade.

Company-level read

Ticker impact

$MCSBullishMedium confidence
Context

Stonex analyst raised Q3 fiscal 2026 revenue to $233M and adjusted EBITDA to $42M, citing stronger box office performance.

Expected impact

likely upward pressure as the market prices in the raised guidance

Evidence & confidence

The new estimates are a fresh data point beyond the already‑released earnings, suggesting improved earnings momentum.

Market effects

Positive outlook for cinema and hospitality sectors may lift peers.

U.S. entertainment stocks could see modest gains.

Limited to U.S. listed entertainment and hotel operators.

Counterpoint

If box office growth stalls, the raised forecasts may be overly optimistic.

Key entities

  • Stonex

    Provided the revised revenue and EBITDA forecasts.

  • Marcus Corp.

    U.S. cinema and hotel operator (NYSE:MCS).

Related articles

$MCSMedAI 8/10

Marcus (MCS) Q3 2026 Earnings Call Transcript

Marcus (MCS) reported Q3 2026 earnings with record revenue of $238M, up 13.1% YoY. Theatres division saw 21% revenue growth, while hotels division grew 2%. Adjusted EBITDA rose 21% to $49.1M. Net earnings were $18.8M, or $0.60 per share, excluding a non-recurring gain.

$MCSMedAI 8/10

Marcus Reports Record Third-Quarter Revenue, Higher Earnings

Marcus Corp reported Q3 2026 revenue of $237.8M, up 13.1% YoY, with operating income rising 33.2% to $30.3M and net earnings increasing 15.6% to $18.8M. Growth was driven by record revenue in theatre and hotel divisions, with Marcus Theatres seeing higher attendance and ticket prices, and Marcus Hotels reporting increased RevPAR.

$MCSMed

MARCUS CORPORATION REPORTS THIRD QUARTER 2026 RESULTS

MARCUS CORP (MCS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 MARCUS CORPORATION REPORTS THIRD QUARTER 2026 RESULTS Marcus Corporation reports highest quarterly revenue in company history thanks to record third quarter revenue from both Marcus Theatres and Marcus Hotels & Resorts Milwaukee, October 29, 2026 … The Marcus Corpora

$AMCMed

AMC vs. MCS: Which Theater Stock Is the Better Buy Today?

AMC and Marcus (MCS) report Q2 2026 earnings growth, with AMC showing 14.2% revenue increase and MCS up 16.6% in theater admissions. AMC's adjusted EBITDA rose 70% to $321.4M, while MCS's theater-adjusted EBITDA increased 37% to $36.3M. MCS has lower leverage (1.1x) and stronger free cash flow, while AMC's recovery hinges on box office growth. Analysts favor MCS for its diversified earnings and higher estimate revisions.

$MCSMed

Marcus Corp Q2 Profit Rises; Shares Climb

Marcus Corp. (MCS) reported Q2 results with net earnings up 116.4% to $15.84M, or $0.51/share, and operating income rising to $27.07M from $13.01M. Adjusted EBITDA increased 43% to $46.2M. Total revenue grew 12.5% to $231.74M. Shares were up about 8.7% at $27.14, per NYSE.